PARIMATCH
16.3.2021 11:30:08 CET | Business Wire | Press release
Parimatch, Juventus’s official betting partner, has launched a brand-new global video campaign featuring top Juventus stars: Arthur Melo, Luiz Da Silva Danilo, Alvaro Morata, Cristiano Ronaldo, and Wojciech Szczesny. The campaign is infused with Parimatch’s yellow electric impulses and aims to increase brand awareness among the football club's fans. The campaign highlights the transition into the online era.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210316005506/en/
The partnership of Juventus and Parimatch is beyond a signed contract. This collaboration is the fusion of two energies, two strong teams, two brands. The power of Juventus is in its remarkable history, a long list of titles, traditions, and unwavering support of millions of fans. The power of Parimatch is in its boldness, youth, ambition, and the absence of barriers.
Ivan Liashenko, CMO at Parimatch, said: “For the last 6 months, we have been watching the partnership of two strong brands providing great entertainment to millions of fans all over the world. Step by step, we are strengthening our partnership and are delighted to see the explosive cocktail created by the complementing energies of Juventus and Parimatch. The connection of outstanding football players representing one of the strongest clubs in the world with Parimatch’s energy and boldness is truly a sight to be seen.”
The creators produced this campaign despite the limitations of the worldwide lockdown. Thanks to the professionalism and efforts of both teams, this commercial could come to life and bring such a legendary team closer to the audience. The partnership of Parimatch and Juventus has proven that anything is possible.
“This new collaboration between Juventus and Parimatch is an excellent example of a campaign being created under extreme quarantine restrictions. Despite this, we tried to convey each player's emotions and charisma in the shades of our brand. I believe that Juventus and Parimatch make a great team, and the video encapsulates the synergy of our raw energies and power perfectly” says Kateryna Amirkhamova, CCO at Parimatch.
The spot was shot by the Ukrainian production house Electric Sheep Film. The directors working on the film were Andrei Copots and Macar Severin. The filming of the spot was carried out by Nikita Kuzmenko, an experienced cameraman who previously worked with Katy Perry and Cardi B. The music was created by Eugeniy Filatov, also known as “The Maneken” – a famous Ukrainian composer and sound producer of ONUKA band.
Electric Sheep Film also carried out the final visualization in collaboration with massa+ motion design boutique.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210316005506/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Brightfin Appoints Preeti Shukla as Chief Product and AI Officer10.8.2026 15:00:00 CEST | Press release
Enterprise AI SaaS leader to accelerate Brightfin's AI-Native platform for IT financial management Brightfin, the only IT Financial Management (ITFM) and Technology Expense Management solution built natively on ServiceNow, today announced the appointment of Preeti Shukla as Chief Product and AI Officer (CPAIO). In this newly created role, Shukla will lead product strategy and artificial intelligence across the Brightfin platform, advancing the company's mission to make every technology decision grounded in financial truth, operational clarity, and intelligent automation. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260810283143/en/ Preeti Shukla, CPAIO of Brightfin Shukla brings two decades of experience building and scaling customer-facing, enterprise-grade B2B SaaS, fintech, and marketplace products across Fortune 100 companies and high-growth startups, including leadership roles at Workday and Oracle. A recognized autho
BeOne Medicines and Revolution Medicines Announce Clinical Development and Regional Commercialization Collaboration10.8.2026 12:00:00 CEST | Press release
Clinical collaboration enables novel combinations of select BeOne oncology assets with four Revolution Medicines clinical-stage RAS(ON) inhibitors for RAS-addicted cancersRegional rights agreement provides BeOne with exclusive development and commercialization rights to four Revolution Medicines clinical assets in select Asian markets BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, and Revolution Medicines, Inc. (Nasdaq: RVMD), a late-stage clinical oncology company developing targeted therapies for patients with RAS-addicted cancers, today announced a multi-part collaboration including: a clinical collaboration to evaluate drug combinations incorporating select clinical-stage oncology assets from BeOne with any of Revolution Medicines’ four clinical RAS(ON) inhibitors, and a separate regional rights agreement granting BeOne exclusive development and commercialization rights to these Revolution Medicines assets in select Asian markets. Clinical
OpenGate Capital to Acquire Maersk Training, the Global Safety Training and Gas-Safety Services Business of Maersk10.8.2026 08:00:00 CEST | Press release
OpenGate Capital (“OpenGate”), a global private equity firm, announced today that it has signed a definitive agreement to acquire Maersk Training and its subsidiary Maersk H2S Safety Services. The company, a provider of global safety training and gas safety services, is being carved out from A.P. Møller - Mærsk A/S (MAERSK A:CPH), a listed integrated logistics company. Headquartered in Svendborg, Denmark, Maersk Training is a leading global provider of essential safety services that operates through two complementary business segments. The first segment, Maersk H2S Safety Services, is a specialist provider of outsourced hydrogen sulphide and Health, Safety and Environment safety services, which include onsite supervision, monitoring and safety equipment maintenance for customers in high-risk operating environments. The second segment, Training Business, is a global provider of safety training, competency development and simulation, delivered through instructor led, digital and virtual
Ant International’s Bettr Partners with Muslim Pro to Introduce Umrah Financing Service in Malaysia10.8.2026 05:49:00 CEST | Press release
Bettr, a leading provider of inclusive and embedded finance and fintech solutions under Ant International, today announced its partnership with Muslim Pro, a popular Islamic lifestyle app serving over 190 million downloads worldwide, to launch an Umrah financing solution in Malaysia. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260809780047/en/ Ant International's Bettr and Muslim Pro launch an Umrah financing solution in Malaysia to help families better manage their cash flow and spread pilgrimage costs responsibly. The solution is designed for eligible Muslims who have the means to undertake the pilgrimage but prefer to spread its cost over time. This flexibility enables individuals and families to manage their cash flow responsibly, maintain regular savings and preserve sufficient liquidity for emergencies and other financial obligations. The launch marks a significant milestone in Bettr’s Islamic finance initiative and
ICC Arbitral Tribunal Issues Quantum Award for AOP Health in BESREMi® Proceedings7.8.2026 19:48:00 CEST | Press release
An ICC Arbitral Tribunal has awarded AOP Orphan Pharmaceuticals GmbH (“AOP Health”) a total of about EUR 112 Mio in a quantum award issued in the ongoing arbitration proceedings with PharmaEssentia Corp. (“PharmaEssentia”) concerning BESREMi® (ropeginterferon alfa-2b). The award quantifies AOP Health’s damage claims for PharmaEssentia’s intentional breaches at ca. EUR 82 Mio. It also awards AOP Health ca. EUR 31 Mio plus interest as reimbursement for AOP Health overpayments made to PharmaEssentia as a result of excessive pricing in the years 2019-2022. The Tribunal thereby confirmed that PharmaEssentia has been overcharging AOP Health by up to 900% over these years. The Tribunal affirmed AOP Health's valid set-off of the profit-sharing payments amount owed to PharmaEssentia of approximately EUR 17 Mio against AOP Health's substantially exceeding damages claims. This means that AOP Health shall not make any payment to PharmaEssentia. Interest on AOP Health’s claims will continue to accr
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom